Prevention of sudden cardiac death in hemodialysis patients

Michelle M O'Shaughnessy, John A O'Regan, Peter J Lavin1

  • 1Trinity Health Kidney Centre, Tallaght Hospital, Trinity College, Dublin, Ireland. michelleoshaugh@gmail.com.

Insights

Sudden cardiac death (SCD) affects one quarter of hemodialysis patients. This review explores unique risk factors and evidence-based strategies to prevent SCD in end-stage kidney disease (ESKD).

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Medicine

Background:

  • Sudden cardiac death (SCD) is a leading cause of mortality in hemodialysis patients, occurring at rates significantly higher than the general population.
  • End-stage kidney disease (ESKD) patients exhibit unique SCD risk factors beyond atherosclerotic coronary artery disease, including uremic cardiomyopathy, electrolyte imbalances, and mineral metabolism derangements.
  • Current interventions for SCD prevention in ESKD are inadequately studied, necessitating careful evaluation of existing evidence and tailored application of general guidelines.

Purpose of the Study:

  • To critically appraise the evidence for interventions aimed at preventing SCD in hemodialysis patients.
  • To discuss the unique risk factors contributing to SCD in the ESKD population.
  • To propose evidence-based strategies for preventing arrhythmia-mediated death in this vulnerable group.

Main Methods:

  • Review of existing literature on SCD in hemodialysis patients.
  • Analysis of risk factors specific to end-stage kidney disease.
  • Discussion of potential interventions including medical therapies, dialysis prescription, revascularization, and electrical therapies.

Main Results:

  • Hemodialysis patients face a disproportionately high risk of SCD due to a combination of traditional cardiovascular risk factors and ESKD-specific issues.
  • Existing data on SCD prevention in non-renal populations may not be directly applicable to hemodialysis patients.
  • A comprehensive approach integrating medical, dialysis-related, and procedural interventions is likely necessary for effective SCD prevention.

Conclusions:

  • Preventing SCD in hemodialysis patients requires addressing unique uremic and dialysis-related factors.
  • Therapeutic nihilism and excessive intervention should be avoided through critical appraisal of evidence.
  • Evidence-based strategies, tailored to the ESKD population, are essential for reducing arrhythmia-mediated death.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
4.0K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.8K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.2K
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
2.2K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.1K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559